Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies.
about
A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disordersEffects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recoveryAdoption of injectable naltrexone in U.S. substance use disorder treatment programsAn organizational readiness intervention and randomized controlled trial to test strategies for implementing substance use disorder treatment into primary care: SUMMIT study protocol.Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexoneTreating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data.Naltrexone: Not Just for Opioids AnymoreLinkage to Primary Care for Persons First Receiving Injectable Naltrexone During Inpatient Opioid Detoxification.Economic Evaluations of Opioid Use Disorder Interventions.Screening, treatment initiation, and referral for substance use disordersPromoting Adoption of Medication for Opioid and Alcohol Use Disorders Through System Change.Extended release naltrexone for alcohol use disorders: quasi-experimental effects on mortality and subsequent detoxification episodes.Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study.Alcohol and Opioid Use, Co-Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review.Perceptions of alcohol use in the context of HIV treatment: a qualitative study.
P2860
Q27000732-7D6E8D3B-086A-45D2-9F2A-4F3DC134D839Q33635582-7432EE05-B254-40F0-A07E-69C023A30B60Q34682257-177D8D82-1CF6-45FE-82FD-B015AD59F70BQ35609744-93BC9DBF-D58E-48B5-84E5-10DA98E47157Q35619851-6B4A814C-B52C-4C14-B2FA-75BCB5A7750FQ36367544-21818F7A-12D8-4BDB-B7BE-20C48F0AF499Q36660846-752C938E-E50B-4015-A9DC-79E3E68A0D67Q36757815-F9D3286D-AB49-4307-8E00-CBE462CF0213Q38784603-AD9416C8-5A62-436D-A3A6-A3FFE989B725Q42342891-185FAAFB-A9E6-49CA-9C20-8C0099E4F9A3Q44349044-3C585B02-412E-40F9-9F9C-BBCE83FCAFD2Q45938302-E1187597-0D58-4012-BA14-35563FA6A35DQ47130417-583B5CD3-B2D5-434F-9E21-49CA223B069FQ47191704-B47CDA88-FA94-4DD2-A3F3-C274C868E39DQ53691763-FC999D39-A440-421E-9835-681C5BD5243D
P2860
Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Extended-release naltrexone fo ...... ealthcare utilization studies.
@ast
Extended-release naltrexone fo ...... ealthcare utilization studies.
@en
type
label
Extended-release naltrexone fo ...... ealthcare utilization studies.
@ast
Extended-release naltrexone fo ...... ealthcare utilization studies.
@en
prefLabel
Extended-release naltrexone fo ...... ealthcare utilization studies.
@ast
Extended-release naltrexone fo ...... ealthcare utilization studies.
@en
P2093
P2860
P1476
Extended-release naltrexone fo ...... ealthcare utilization studies.
@en
P2093
Daniel M Hartung
David R Gastfriend
Dennis McCarty
Katharina Wiest
Mady Chalk
Rongwei Fu
P2860
P304
P356
10.1016/J.JSAT.2014.03.007
P577
2014-04-13T00:00:00Z